Combination therapy with an angiotensin II receptor blocker and an HMG-CoA reductase inhibitor in experimental subtotal nephrectomy

被引:10
作者
Alvarez-Prats, Alejandro [1 ]
Hernandez-Perera, Octavio [1 ]
Diaz-Herrera, Pilar [3 ]
Ucero, Alvaro C. [4 ]
Anabitarte-Prieto, Aranzazu [1 ]
Losada-Cabrera, Antonio [1 ]
Ortiz, Alberto [4 ]
Rodriguez-Perez, Jose C. [1 ,2 ]
机构
[1] Hosp Univ Gran Canaria Dr Negrin, Res Unit, Las Palmas Gran Canaria, Spain
[2] Hosp Univ Gran Canaria Dr Negrin, Serv Nephrol, Las Palmas Gran Canaria, Spain
[3] Hosp Univ Gran Canaria Dr Negrin, Dept Morphol, Las Palmas Gran Canaria, Spain
[4] Univ Autonoma Madrid, IIS Fdn Jimenez Diaz, Madrid, Spain
关键词
angiotensin II receptor blocker; HMG-CoA reductase inhibitor; NF-B; subtotal nephrectomy; NF-KAPPA-B; EXPERIMENTAL RENAL-INSUFFICIENCY; SPONTANEOUSLY HYPERTENSIVE RATS; VASCULAR ENDOTHELIAL-CELLS; URINARY ALBUMIN EXCRETION; LIMITS GLOMERULAR INJURY; REMNANT KIDNEY MODEL; BLOOD-PRESSURE; TUBULOINTERSTITIAL INJURY; GENE-EXPRESSION;
D O I
10.1093/ndt/gfr671
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Angiotensin receptor 1 blockers (ARB) are standard nephroprotective drugs in chronic kidney disease. There is less evidence for a nephroprotective effect of HMG-CoA reductase inhibitors (statins) and much less is known about potential benefits of combination therapy. We evaluated the therapeutic potential of a statin alone or in combination with an ARB in experimental chronic kidney disease. Subtotally nephrectomized (5/6 Nx) rats were treated early with vehicle, losartan, cerivastatin or losartan/cerivastatin. Expression of messenger RNA (mRNA) was assessed by real-time reverse transcriptionpolymerase chain reaction. Tissue proteins were localized by immunohistochemistry. Nuclear factor-B (NF-B) activation was measured in whole kidneys. In contrast to the sham group, at 6 weeks, vehicle-treated 5/6 Nx rats displayed renal lesions, albuminuria and increased blood pressure, serum creatinine and total kidney NF-B p65 DNA-binding activity and preproendothelin-1, fibronectin and type I and III collagen mRNA. NF-B activation correlated with albuminuria and histological renal injury. Losartan or combination therapy preserved renal function, abrogated albuminuria and improved glomerular and interstitial histology. Cerivastatin alone preserved renal function and improved interstitial injury but did not influence albuminuria, glomerular histology or NF-B activation. Losartan/cerivastatin normalized kidney NF-B activation and extracellular matrix mRNA expression pattern. The effect of losartan alone on these parameters was less intense. All treatments decreased preproendothelin-1 mRNA and preserved interstitial capillaries. In a chronic kidney disease model, early treatment with either an ARB or a statin preserved renal function although the mechanisms differed. Combination therapy with an ARB and a statin did not confer clear-cut advantages on biochemical and histological parameters over ARB alone, although it further improved the kidney NF-B and gene expression profile.
引用
收藏
页码:2720 / 2733
页数:14
相关论文
共 61 条
[1]   CONTROL OF GLOMERULAR HYPERTENSION LIMITS GLOMERULAR INJURY IN RATS WITH REDUCED RENAL MASS [J].
ANDERSON, S ;
MEYER, TW ;
RENNKE, HG ;
BRENNER, BM .
JOURNAL OF CLINICAL INVESTIGATION, 1985, 76 (02) :612-619
[2]   The effect of statins on urinary albumin excretion and glomerular filtration rate: results from both a randomized clinical trial and an observational cohort study [J].
Atthobari, Jarir ;
Brantsma, Auke H. ;
Gansevoort, Ron T. ;
Visser, Sipke T. ;
Asselbergs, Folkert W. ;
van Gilst, Wiek H. ;
de Jong, Paul E. ;
de Jong-van den Berg, Lolkje T. W. .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 (11) :3106-3114
[3]   NF-κB in Renal Inflammation [J].
Belen Sanz, Ana ;
Dolores Sanchez-Nino, Maria ;
Mario Ramos, Adrian ;
Antonio Moreno, Juan ;
Santamaria, Beatriz ;
Ruiz-Ortega, Marta ;
Egido, Jesus ;
Ortiz, Alberto .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2010, 21 (08) :1254-1262
[4]   Blocking both type A and B endothelin receptors in the kidney attenuates renal injury and prolongs survival in rats with remnant kidney [J].
Benigni, A ;
Zoja, C ;
Corna, D ;
Orisio, S ;
Facchinetti, D ;
Benatti, L ;
Remuzzi, G .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1996, 27 (03) :416-423
[5]   Cerivastatin: pharmacology of a novel synthetic and highly active HMG-CoA reductase inhibitor [J].
Bischoff, H ;
Angerbauer, R ;
Bender, J ;
Bischoff, E ;
Faggiotto, A ;
Petzinna, D ;
Pfitzner, J ;
Porter, MC ;
Schmidt, D ;
Thomas, G .
ATHEROSCLEROSIS, 1997, 135 (01) :119-130
[6]   HEMODYNAMICALLY MEDIATED GLOMERULAR INJURY AND THE PROGRESSIVE NATURE OF KIDNEY-DISEASE [J].
BRENNER, BM ;
KASSIRER, JP ;
MADIAS, NE ;
NARAYAN, G ;
HARRINGTON, JT .
KIDNEY INTERNATIONAL, 1983, 23 (04) :647-655
[7]  
Bruzzi I, 1997, AM J PATHOL, V151, P1241
[8]   TAIL-CUFF BLOOD-PRESSURE MEASUREMENT WITHOUT EXTERNAL PREHEATING IN AWAKE RATS [J].
BUNAG, RD ;
BUTTERFIELD, J .
HYPERTENSION, 1982, 4 (06) :898-903
[9]   Are 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors renoprotective? [J].
Campese, VM ;
Nadim, MK ;
Epstein, M .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 :S11-S17
[10]   Angiotensin type 2 receptor antagonism confers renal protection in a rat model of progressive renal injury [J].
Cao, ZM ;
Bonnet, F ;
Candido, R ;
Nesteroff, SP ;
Burns, WC ;
Kawachi, H ;
Shimizu, F ;
Carey, RM ;
De Gasparo, M ;
Cooper, ME .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 (07) :1773-1787